Doctor profile · Federal record
Dr. IMAD KHDAIR, MD
Internal Medicine Physician (CMS: INTERNAL MEDICINE) · Internal Medicine Physician · SYLACAUGA, AL
- NPI 1093725624
- Accepts Medicare
- 44 yrs in practice
- Licensed in 2 states
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
209 W SPRING ST, SUITE 200
SYLACAUGA, AL 351502973
(256) 245-5241
fax (256) 245-0194 - Mailing address
-
1816 SUMMIT PL
BIRMINGHAM, AL 352433141
Credentials & registration
- NPI registered
- August 2006 — 20 yrs on file
- Profile last updated
- October 17, 2011
- Year of graduation
- 1982 — 44 yrs since
- Specialty taxonomy
- 207R00000X — NUCC code
- State licenses (2)
- Kentucky #28198 · Alabama #30074
- Medicaid (2)
- KY #64281983 · AL #120103
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1093725624. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
1,147
Distinct HCPCS
10
Medicare allowed
$85,841
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 447 | 184 | $83 | |
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 129 | 90 | $74 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 67 | 58 | $51 | |
99222 |
Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 60 | 57 | $121 | |
99238 |
Hospital discharge day management, 30 minutes or less | 59 | 54 | $74 | |
G0446 |
Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | 49 | 49 | $24 | |
J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 48 | 15 | $6 | |
99231 |
Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | 43 | 33 | $46 | |
G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 37 | 37 | $119 | |
G0008 |
Administration of influenza virus vaccine | 32 | 32 | $29 |
In context: peer comparison
Among 3 peers in this city , average services per provider: 114. This provider delivers 10× the peer median.Open Payments
Industry payments received
All-time total
$190
Transactions
11
Manufacturers
9
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 2 | $38.09 | |
| GlaxoSmithKline, LLC. | 2 | $32.36 | |
| Xeris Pharmaceuticals, Inc. | 1 | $20.96 | |
| AstraZeneca Pharmaceuticals LP | 1 | $19.64 | |
| Novo Nordisk Inc | 1 | $17.05 | |
| Lilly USA, LLC | 1 | $16.00 | |
| PFIZER INC. | 1 | $15.72 | |
| Amgen Inc. | 1 | $15.35 | |
| SHIELD THERAPEUTICS INC | 1 | $15.21 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
7,135
Patients
2,013
Total drug cost
$992,153
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Amlodipine Besylate | Generic | 820 | 244 | $7,093 |
| Atorvastatin Calcium | Generic | 739 | 220 | $12,183 |
| Levothyroxine Sodium | Generic | 646 | 142 | $12,855 |
| Pantoprazole Sodium | Generic | 530 | 158 | $11,100 |
| Gabapentin | Generic | 508 | 116 | $9,656 |
| Carvedilol | Generic | 485 | 143 | $6,750 |
| Alprazolam | Generic | 445 | 74 | $1,256 |
| Ozempic (Semaglutide) | Brand | 424 | 80 | $531,694 |
| Fluticasone Propionate | Generic | 396 | 159 | $6,097 |
| Azithromycin | Generic | 395 | 269 | $2,023 |